Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 29, 2024.
All times in Eastern Daylight Time.
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C ReactivatorBOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--Foundation Medicine and PMV Pharma partner to develop FoundationOne®CDx as a companion diagnostic for PMV Pharma’s rezatapopt. more »
-
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare ConferenceWATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indicati... more »
-
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart DiseasesRAMAT-GAN, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncolog... more »
-
ABBYY Recognized as a Leader in Everest Group’s Intelligent Document Processing Products PEAK Matrix® Assessment 2024 for Sixth Consecutive YearMILPITAS, Calif.--(BUSINESS WIRE)--ABBYY is recognized for the 6th consecutive year as a Leader in Everest Group’s Intelligent Document Processing Products PEAK Matrix® Assessment 2024. more »
-
Electric Vehicle Brands Must Improve Mobile App Connectivity to Meet Owners’ Needs, J.D. Power FindsTROY, Mich.--(BUSINESS WIRE)--J.D. Power: Electric Vehicle Brands Must Improve Mobile App Connectivity to Meet Owners’ Needs more »
-
Element 1 Corp. and Ballard Power Systems Collaborate on Revolutionary Hydrogen Power SolutionsBEND, Ore.--(BUSINESS WIRE)--Element 1 Corp, a pioneer in on-demand hydrogen generation technology, and Ballard Power Systems (NASDAQ: BLDP; TSX: BLDP), have joined forces to accelerate the adoptio... more »
-
Covalon Announces Profitable Second Quarter Fiscal 2024 ResultsMISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 se... more »
-
ReposiTrak Adds 25 New Produce Companies to the Queue for the Rapidly Expanding Food Traceability NetworkSALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak queues new produce companies for its network, ensuring FSMA 204 compliance with a cloud-based solution, no extra hardware needed more »
-
Davies’ Evaluation Endorses DataVisor’s Enhanced AML/BSA Solutions, Affirming Operational Integrity and Seamless Investigation Processes for FIsMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DataVisor, the world’s leading AI-powered fraud and financial crime prevention platform, announced today that it partnered with Davies, a consultancy focusin... more »
-
Trinity Lutheran School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All StudentsCONKLIN, Mich. & ST. LOUIS--(BUSINESS WIRE)--Trinity Lutheran School today announced an exciting partnership with Varsity Tutors for Schools, a Nerdy (NYSE: NRDY) company and the leading platform f... more »
-
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated a... more »
-
Alentis Receives FDA Orphan Drug Designation for Lixudebart to Treat Idiopathic Pulmonary FibrosisBASEL, Switzerland--(BUSINESS WIRE)--Lixudebart (ALE.F02) is a first-in-class monoclonal antibody in clinical development for multi-organ fibrosis. more »
-
Viking Reports First Quarter 2024 Financial ResultsLOS ANGELES--(BUSINESS WIRE)--Viking Holdings Ltd (the “Company” or “Viking”) (NYSE: VIK) today reported financial results for the first quarter ended March 31, 2024. Key Highlights Adjusted Gross ... more »
-
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective DataPALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, is partnering with industry leader Masimo (NASDAQ: MASI) to bring best-in-class medical... more »
-
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 MillionEDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has enter... more »